Stocks rose Wednesday on promising new COVID-19 vaccine data from Moderna Therapeutics, although much of the optimism is outpacing the science.
Axios Re:Cap digs into what Moderna said, what it didn't say, and what comes next in the vaccine race with Richard Besser, former acting director of the CDC and current CEO of the Robert Wood Johnson Foundation.
